This inventor holds 1 USPTO granted patent and 10 published patent applications and 1 EPO patent. Top assignee: Icahn School of Medicine at Mount Sinai. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: The Innovative Contributions of Jordi Ochando
Introduction
Jordi Ochando is a notable inventor based in New York, NY (US). He has made significant strides in the field of immunology, particularly in developing methods to target the innate immune system. His work aims to induce long-term tolerance and resolve macrophage accumulation in atherosclerosis.
Latest Patents
Jordi Ochando holds 1 patent titled "Targeting the innate immune system to induce long-term tolerance and to resolve macrophage accumulation in atherosclerosis." This patent provides methods and compositions for inducing long-term tolerance by utilizing hybrid nanoparticles. The compositions and formulations he developed comprise hybrid nanoparticles with an inherent affinity for innate immune cells.
Career Highlights
Jordi is affiliated with the Icahn School of Medicine at Mount Sinai, where he continues to contribute to groundbreaking research in immunology. His innovative approaches have the potential to transform treatment strategies for various immune-related conditions.
Collaborations
He has collaborated with esteemed colleagues such as Willem Mulder and Zahi A Fayad, further enhancing the impact of his research through teamwork and shared expertise.
Conclusion
Jordi Ochando's work exemplifies the intersection of innovation and medical research, showcasing how targeted approaches can lead to significant advancements in healthcare. His contributions are paving the way for future developments in immunology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile